QUOTED. 29 March 2021. Karen Burke.
A US FDA panel discussed ways to fight adverse events associated with dermal fillers. The agency’s suggestion that filler labeling incorporate an injection information card for patients to take home drew support from panelist Karen Burke, a dermatology professor at Mount Sinai Medical Center.
“We all have had patients who came to us with nodules and don’t know what was injected and are kind of vague about when it was. I think this would be so great because they’d at least know what they had, and we’d know what we’re treating.” – Karen Burke, professor of dermatology, Mount Sinai Medical Center
- > Find out more: US FDA Panel Grapples With Dermal Filler Adverse Events
Click here for a free trial of Medtech Insight